Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science (Animal or Phantoms)

99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET

Filipe Elvas, Jan Boddaert, Christel Vangestel, Koon Pak, Brian Gray, Samir Kumar-Singh, Steven Staelens, Sigrid Stroobants and Leonie wyffels
Journal of Nuclear Medicine November 2016, jnumed.116.182014; DOI: https://doi.org/10.2967/jnumed.116.182014
Filipe Elvas
1 University of Antwerp, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Boddaert
1 University of Antwerp, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christel Vangestel
1 University of Antwerp, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koon Pak
2 Molecular Targeting Technologies, Inc., United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Gray
2 Molecular Targeting Technologies, Inc., United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samir Kumar-Singh
1 University of Antwerp, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Staelens
3 Antwerp University, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sigrid Stroobants
4 University Hospital Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonie wyffels
4 University Hospital Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.116.182014
DOI 
https://doi.org/10.2967/jnumed.116.182014
PubMed 
27879368

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 22, 2016.

Article Versions

  • You are currently viewing a previous version of this article (November 22, 2016 - 12:00).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Filipe Elvas1,
  2. Jan Boddaert1,
  3. Christel Vangestel1,
  4. Koon Pak2,
  5. Brian Gray2,
  6. Samir Kumar-Singh1,
  7. Steven Staelens3,
  8. Sigrid Stroobants4 and
  9. Leonie wyffels4
  1. 1 University of Antwerp, Belgium;
  2. 2 Molecular Targeting Technologies, Inc., United States;
  3. 3 Antwerp University, Belgium;
  4. 4 University Hospital Antwerp, Belgium
  1. For correspondence or reprints contact: Leonie Wyffels, University Hospital Antwerp, Wilrijkstraat 10, Edegem 2650, Belgium. E-mail: leonie.wyffels@uza.be

Statistics from Altmetric.com

Cited By...

  • 43 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging
    Prashant Kesharwani, Hira Choudhury, Jaya Gopal Meher, Manisha Pandey, Bapi Gorain
    Progress in Materials Science 2019 103
  • Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides
    Chayanid Ongpipattanakul, Emily K. Desormeaux, Adam DiCaprio, Wilfred A. van der Donk, Douglas A. Mitchell, Satish K. Nair
    Chemical Reviews 2022 122 18
  • SPECT/CT: Standing on the Shoulders of Giants, It Is Time to Reach for the Sky!
    Tim Van den Wyngaert, Filipe Elvas, Stijn De Schepper, John A. Kennedy, Ora Israel
    Journal of Nuclear Medicine 2020 61 9
  • A “Self‐Checking” pH/Viscosity‐Activatable NIR‐II Molecule for Real‐Time Evaluation of Photothermal Therapy Efficacy
    Benhao Li, Hengke Liu, Yaling He, Mengyao Zhao, Chen Ge, Muhammad Rizwan Younis, Peng Huang, Xiaoyuan Chen, Jing Lin
    Angewandte Chemie International Edition 2022 61 16
  • SPECT/CT imaging of chemotherapy-induced tumor apoptosis using 99mTc-labeled dendrimer-entrapped gold nanoparticles
    Yan Xing, Jingyi Zhu, Lingzhou Zhao, Zhijuan Xiong, Yujie Li, San Wu, Gitasha Chand, Xiangyang Shi, Jinhua Zhao
    Drug Delivery 2018 25 1
  • Phosphatidylethanolamine targeting for cell death imaging in early treatment response evaluation and disease diagnosis
    Filipe Elvas, Sigrid Stroobants, Leonie Wyffels
    Apoptosis 2017 22 8
  • Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death–Dependent Changes in Glycolysis
    Richard L. Hesketh, Jiazheng Wang, Alan J. Wright, David Y. Lewis, Alice E. Denton, Richard Grenfell, Jodi L. Miller, Robert Bielik, Marcel Gehrung, Maria Fala, Susana Ros, Bangwen Xie, De-en Hu, Kevin M. Brindle
    Cancer Research 2019 79 14
  • Avenues to molecular imaging of dying cells: Focus on cancer
    Anna A. Rybczynska, Hendrikus H. Boersma, Steven de Jong, Jourik A. Gietema, Walter Noordzij, Rudi A. J. O. Dierckx, Philip H. Elsinga, Aren van Waarde
    Medicinal Research Reviews 2018 38 6
  • Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma
    Pengcheng Hu, Zhequan Fu, Guobing Liu, Hui Tan, Jie Xiao, Hongcheng Shi, Dengfeng Cheng
    Frontiers in Bioengineering and Biotechnology 2019 7
  • Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy
    Filipe Elvas, Tom Vanden Berghe, Yves Adriaenssens, Peter Vandenabeele, Koen Augustyns, Steven Staelens, Sigrid Stroobants, Pieter Van der Veken, Leonie wyffels
    Organic & Biomolecular Chemistry 2019 17 19

Article usage

Article usage: November 2016 to April 2025

AbstractFullPdf
Nov 2016655037
Dec 2016335043
Jan 2017155028
Feb 2017117121
Mar 201765018
Apr 20177952274
May 20172211026
Jun 20171521517
Jul 201782819
Aug 201773719
Sep 20173726
Oct 2017781220
Nov 2017622120
Dec 2017311211
Jan 2018462326
Feb 2018322210
Mar 2018361713
Apr 2018282422
May 20182878
Jun 2018211212
Jul 201816357
Aug 20181192
Sep 20182285
Oct 20181786
Nov 2018152920
Dec 201851114
Jan 201919610
Feb 201928911
Mar 2019281232
Apr 201917814
May 20191798
Jun 201910107
Jul 201926813
Aug 20191487
Sep 20192979
Oct 20191776
Nov 201918916
Dec 201914311
Jan 2020341521
Feb 20201669
Mar 202018713
Apr 20201439
May 202018913
Jun 202018810
Jul 20201138
Aug 20209412
Sep 20201946
Oct 2020291810
Nov 20201158
Dec 20201498
Jan 202191612
Feb 202121113
Mar 202172510
Apr 20217174
May 20213388
Jun 20215359
Jul 202153618
Aug 20214296
Sep 20215166
Oct 202131627
Nov 202161919
Dec 202182110
Jan 20229209
Feb 20226214
Mar 202223814
Apr 20220328
May 20224459
Jun 202221918
Jul 20224148
Aug 20228187
Sep 20224118
Oct 20223168
Nov 202232111
Dec 20223205
Jan 2023114110
Feb 20235208
Mar 202341912
Apr 202372520
May 202321625
Jun 202312019
Jul 202312211
Aug 202342016
Sep 20231264
Oct 202351910
Nov 202311168
Dec 202373410
Jan 20248246
Feb 20240214
Mar 2024511122
Apr 202482519
May 202461079
Jun 2024102312
Jul 202492014
Aug 2024103620
Sep 202424617
Oct 20248227
Nov 202492313
Dec 20240132
Jan 202572421
Feb 2025197317
Mar 202573330
Apr 2025142923
Next
Back to top

In this issue

Journal of Nuclear Medicine: 66 (6)
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET
Filipe Elvas, Jan Boddaert, Christel Vangestel, Koon Pak, Brian Gray, Samir Kumar-Singh, Steven Staelens, Sigrid Stroobants, Leonie wyffels
Journal of Nuclear Medicine Nov 2016, jnumed.116.182014; DOI: 10.2967/jnumed.116.182014

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET
Filipe Elvas, Jan Boddaert, Christel Vangestel, Koon Pak, Brian Gray, Samir Kumar-Singh, Steven Staelens, Sigrid Stroobants, Leonie wyffels
Journal of Nuclear Medicine Nov 2016, jnumed.116.182014; DOI: 10.2967/jnumed.116.182014
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • SPECT/CT: Standing on the Shoulders of Giants, It Is Time to Reach for the Sky!
  • Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis
  • Google Scholar

Similar Articles

Keywords

  • Animal Imaging
  • molecular imaging
  • Peptides
  • PET/CT
  • radiopharmaceuticals
  • SPECT/CT
  • 99mTc-duramycin SPECT
  • Cell death imaging
  • colorectal cancer
  • response evaluation
  • targeted therapy
SNMMI

© 2025 SNMMI

Powered by HighWire